MannKind posts mixed Q2

Shares in MannKind Corp. (NSDQ:MNKD) fell slightly this morning after the biopharmaceutical company missed earnings expectations but beat sales estimates on Wall Street with its second quarter results.

The Valencia, Calif.-based company posted a net loss of -$35.4 million on sales of $2.2 million for the 3 months ended June 30, for bottom-line loss of -18% on sales growth of 100% compared with the same period last year.

Get the full story at out sister site, Drug Delivery Business News.

The post MannKind posts mixed Q2 appeared first on MassDevice.

from MassDevice http://ift.tt/2vBQzi8